Cullinan Therapeutics Inc (CGEM)

SG&A Expenses

$12.82M

Quarterly · Period ending: · USD

CGEM logo

CGEM SG&A Expenses

Latest reported$12.82M
CGEM Quarterly SG&A Expenses ($1.31M → $12.82M)
High-resolution chart · PNG

CGEM sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cullinan Therapeutics Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
12,817,000
11,574,000
12,314,000
13,627,000
14,768,000
13,537,000
14,556,000
13,349,000
13,691,000
12,267,000
10,560,000
10,982,000
10,214,000
10,660,000
11,287,000
10,086,000
10,695,000
8,121,000
13,469,000
5,695,000
4,826,000
5,156,000
12,544,000
1,586,000
1,626,000
1,368,000
1,177,000
1,677,000
1,314,000
1,314,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.